Inhibition of 72 kDa inositol polyphosphate 5-phosphatase E improves insulin signal transduction in diet-induced obesity.
The 72 kDa inositol polyphosphate 5-phosphatase E (72k-5ptase) controls signal transduction through the catalytic dephosphorylation of the 5-position of membrane-bound phosphoinositides. The reduction of 72k-5ptase expression in the hypothalamus results in improved hypothalamic insulin signal transduction and reduction of food intake and body mass. Here, we evaluated the tissue distribution and the impact of obesity on the expression of 72k-5ptase in peripheral tissues of experimental animals. In addition, insulin signal transduction and action were determined in an animal model of obesity and insulin resistance treated with an antisense (AS) oligonucleotide that reduces 72k-5ptase expression. In lean Wistar rats, 72k-5ptase mRNA and protein are found in highest levels in heart, skeletal muscle, and white adipose tissue. In three distinct models of obesity, Wistar rats, Swiss mice fed on high-fat diet, and leptin-deficient ob/ob mice, the expression of 72k-5ptase is increased in skeletal muscle and adipose tissue. The treatment of obese Wistar rats with an anti-72k-5ptase AS oligonucleotide results in significant reduction of 72k-5ptase catalytic activity, which is accompanied by reduced food intake and body mass and improved insulin signal transduction and action as determined by immunoblotting and clamp studies respectively. 72k-5ptase expression is increased in obesity and its AS inhibition resulted in a significant improvement in insulin signal transduction and restoration of glucose homeostasis.
Laboratory of Cell Signaling, Department of Internal Medicine, Faculty of Applied Sciences and Department of Nursing, University of Campinas, DCM-FCM, UNICAMP, 13084-970, Campinas, SP, Brazil.
Daniela F
DF
Bertelli
Andressa
A
Coope
Andrea M
AM
Caricilli
Patricia O
PO
Prada
Mario J
MJ
Saad
Licio A
LA
Velloso
Eliana P
EP
Araujo
D052436:Adipose Tissue, White / Q000201:enzymology; D000818:Animals; D059305:Diet, High-Fat / Q000009:adverse effects*; D004195:Disease Models, Animal; D000072181:Inositol Polyphosphate 5-Phosphatases; D007328:Insulin / Q000502:physiology*; D007333:Insulin Resistance / Q000502:physiology; D020738:Leptin / Q000172:deficiency; D008297:Male; D051379:Mice; D008820:Mice, Obese; D018482:Muscle, Skeletal / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D009765:Obesity / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology*; D020320:Oligoribonucleotides, Antisense / Q000494:pharmacology; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors* / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D015398:Signal Transduction / Q000502:physiology*
D007328:Insulin; D020738:Leptin; D020320:Oligoribonucleotides, Antisense; D010744:Phosphoric Monoester Hydrolases; D000072181:Inositol Polyphosphate 5-Phosphatases; C000606432:Inpp5a protein, mouse